Supernus Pharmaceuticals, Inc. Common Stock (SUPN) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Supernus Pharmaceuticals, Inc. Common Stock (SUPN) Stock ... Supernus Pharmaceuticals, Inc. Common Stock (SUPN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Supernus Pharmaceuticals, Inc. (SUPN) Stock Price, Quote ... Find the latest Supernus Pharmaceuticals, Inc. (SUPN) stock quote, history, news and other vital information to help you with your stock trading and investing.
View the latest Supernus Pharmaceuticals Inc. (SUPN) stock price, news, historical charts, analyst ratings and financial information from WSJ.
23 Mar 2020 I fully except $SUPN will have an all stock deal in place very soon. to get a drug to market and increase revenue so to increase shareholder value. 🤔 NEOS's value proposition is the extended release & NEOSRxConnect. Return vs Market: SUPN underperformed the US Market which returned -15.1% over the Are Insiders Buying Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Stock? It offers Oxtellar XR, an extended-release oxcarbazepine for use in the 30 Mar 2020 The Company offers Oxtellar XR (extended-release oxcarbazepine) and Trokendi XR (extended-release topiramate), its two treatments for. Open. 17.07. Previous Close. 17.09. Volume (Avg). 436.39k (781.32k). Day's Range. 16.66-17.58. 52Wk Range. 13.12-39.15. Market Cap. 897.81M. Dividend 11 Oct 2016 Supernus Pharmaceuticals Inc (NASDAQ:SUPN) spiked 2% out of the gate After all, the market opportunity for ADHD treatments is outsized. The Company offers Oxtellar XR (extended-release oxcarbazepine) and to address unmet medical needs and market opportunities for the treatment of 26 Jun 2012 After the market closed, they announced a secondary, so this stock was down after hours. Be careful on this one, and look for some kind of
In depth view into SUPN (Supernus Pharmaceuticals) stock including the latest price, news, Market Cap, 880.47M Top Pharmaceutical Stocks for Q2 2020.
On The Fly - On The Fly: After Hours Movers SCS;DRNA;NBRV ... On The Fly: After Hours Movers. UP AFTER EARNINGS: Steelcase (SCS), up 3.5% after reporting Q2 earnings and giving Q3 guidance. . up 6% after filing to sell $80M in common stock. LOWER: Supernus (SUPN), down 4.3% after announcing the interim analysis of its SPN-810 trial, and eliminating the 18mg dose Beacon Roofing (BECN), lower by 4.7% On The Fly: After Hours Movers SCS;DRNA;NBRV;SUPN;BECN ... On The Fly: After Hours Movers. UP AFTER EARNINGS: Steelcase (SCS), up 3.5% after reporting Q2 earnings and giving Q3 guidance. . up 6% after filing to sell $80M in common stock. LOWER: Supernus (SUPN), down 4.3% after announcing the interim analysis of its SPN-810 trial, and eliminating the 18mg dose Beacon Roofing (BECN), lower by 4.7% SUPN - Supernus Pharmaceuticals Inc Stock quote - … Find real-time SUPN - Supernus Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. SUPN - Supernus Pharmaceuticals Inc Stock quote - CNNMoney.com Markets
Supernus Pharmaceuticals, Inc. (SUPN) Net Income ...
Dividend Yield (TTM) is a widely used stock evaluation measure. Find the latest Dividend Yield (TTM) for Supernus Pharmaceuticals, Inc. (SUPN) Skip … SUPN | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for SUPERNUS PHARMACEUTICALS INC (SUPN), including profile, stock chart, recent news and … Supernus Pharmaceuticals Earnings Release Date - SUPN ... This data point is very helpful if you choose to trade Earnings Result of SUPN in the same Extended Trading Hours as it is announced. If the SUPN trading volume in extended hours is less than 50% of next day volume, there is a great amount of probability for the stock to move in that direction following regular trading session.
View Supernus Pharmaceuticals Inc. (SUPN) Stock Price for pre-market, after-hours and regular trading sessions in a minute-by-minute Volume-Weighted Average Price (VWAP) table.
Apr 03, 2020 · View today's stock price, news and analysis for Supernus Pharmaceuticals Inc. (SUPN). Barron's also provides information on historical stock ratings, target prices, company earnings, market SUPN Stock Quote - Supernus Pharmaceuticals, Inc. Stock ...